On the 25 March 2021, Emma Jewkes, UK Sales Director at Brown Advisory hosted a virtual panel discussion with Brown Advisory’s equity research analysts, Sanjeev Joshi, CFA and Sung Park, CFA to hear their latest thoughts on the health care sector a year after the WHO declared COVID-19 a global pandemic, and at the outset of the Biden administration. The panel discussed the current trends they are seeing in the market, the effect of COVID-19 on the sector, the direction of the Biden administration and the areas of the sector they are most excited to see develop.

If you missed the live event or would like a recap please see below for a recording of the discussion and a written event summary.

Investment Insights: What you need to know about Technology in 2021

On the 27 January 2021, Priyanka Agnihotri, Head of the Equity Research Team at Brown Advisory in London and our Equity Research Analysts, John Canning and Lauren Cahalan took part in a virtual panel discussion on What you need to know about Technology in 2021. The team discussed how they think about investing in technology in the face of wildly increasing valuations and an ever-changing regulatory landscape. Listen now >

The views expressed are those of the author and Brown Advisory as of the date referenced and are subject to change at any time based on market or other conditions. These views are not intended to be and should not be relied upon as investment advice and are not intended to be a forecast of future events or a guarantee of future results. Past performance is not a guarantee of future performance. The information provided in this material is not intended to be and should not be considered to be a recommendation or suggestion to engage in or refrain from a particular course of action or to make or hold a particular investment or pursue a particular investment strategy, including whether or not to buy, sell, or hold any of the securities mentioned. It should not be assumed that investments in such securities have been or will be profitable. To the extent specific securities are mentioned, they have been selected by the author on an objective basis to illustrate views expressed in the commentary and do not represent all of the securities purchased, sold or recommended for advisory clients. The information contained herein has been prepared from sources believed reliable but is not guaranteed by us as to its timeliness or accuracy, and is not a complete summary or statement of all available data. This piece is intended solely for our clients and prospective clients, is for informational purposes only, and is not individually tailored for or directed to any particular client or prospective client.